Drug
Chr 2797
Chr 2797: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CHR-2797 (tosedostat) NCT00692354 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Chr 2797 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.